LNTEF yields 4.03% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, LNTEF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of LNTEF + MRK for your $10,000?
LINTEC Corporation develops, manufactures, and sells adhesive-related products in Japan and internationally. It operates through three segments: Printing and Industrial Materials Products, Electronic and Optical Products, and Paper and Converted Products. The Printing and Industrial Materials Products segment offers adhesive products for seals and labels, labeling machines, automobile-use adhesive products, and industrial-use adhesive tapes; window, marking, and automotive films; barcode label supplies and printers, digital label printing machines, films for outdoor signs and advertising, and interior finishing mounting films. The Electronic and Optical Products segment provides semiconductor-related adhesive tapes and equipment, multilayer ceramic capacitor related tapes, and optical display-related adhesive products. The Paper and Converted Products segment offers color papers for envelopes, colored construction papers, special function papers, high-grade printing papers, high-grade papers for paper products, release papers for adhesive products, release films for optical-related products, casting papers for synthetic leather, and casting papers for carbon fiber composite materials. The company was formerly known as FSK Corporation and changed its name to LINTEC Corporation in April 1990. The company was founded in 1927 and is headquartered in Tokyo, Japan.
Full LNTEF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.